Jack Bravo

28 Publications

Mark all

[28]
2025 | Published | Journal Article | IST-REx-ID: 18848 | OA
Ocampo RF, Bravo JPK, Dangerfield TL, Nocedal I, Jirde SA, Alexander LM, Thomas NC, Das A, Nielson S, Johnson KA, Brown CT, Butterfield CN, Goltsman DSA, Taylor DW. 2025. DNA targeting by compact Cas9d and its resurrected ancestor. Nature Communications. 16, 457.
[Published Version] View | Files available | DOI | PubMed | Europe PMC
 
[27]
2025 | In Press | Journal Article | IST-REx-ID: 20143 | OA | PlanS
Zhang Z, Todeschini TC, Wu Y, Kogay R, Naji A, Cardenas Rodriguez J, Mondi R, Kaganovich D, Taylor DW, Bravo JPK, Teplova M, Amen T, Koonin E, Patel DJ, Nobrega FL. Kiwa is a membrane-embedded defense supercomplex activated at phage attachment sites. Cell.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[26]
2024 | Published | Journal Article | IST-REx-ID: 17113 | OA
Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. 2024. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nature Communications. 15, 3663.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[25]
2024 | Published | Journal Article | IST-REx-ID: 17114 | OA
Schwartz EA, Bravo JPK, Ahsan M, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Palermo G, Fineran PC, Fagerlund RD, Taylor DW. 2024. RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. 15, 3324.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[24]
2024 | Published | Journal Article | IST-REx-ID: 18545 | OA
Degtev D, Bravo JPK, Emmanouilidi A, Zdravković A, Choong OK, Liz Touza J, Selfjord N, Weisheit I, Francescatto M, Akcakaya P, Porritt M, Maresca M, Taylor D, Sienski G. 2024. Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles. Nature Communications. 15, 9173.
[Published Version] View | Files available | DOI
 
[23]
2024 | Published | Journal Article | IST-REx-ID: 17111
Kamatar A, Bravo JPK, Yuan F, Wang L, Lafer EM, Taylor DW, Stachowiak JC, Parekh SH. 2024. Lipid droplets as substrates for protein phase separation. Biophysical Journal. 123(11), 1494–1507.
View | DOI | PubMed | Europe PMC
 
[22]
2024 | Published | Journal Article | IST-REx-ID: 15372 | OA
Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. 2024. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nature Communications. 15, 3663.
[Published Version] View | Files available | DOI | PubMed | Europe PMC
 
[21]
2024 | Published | Journal Article | IST-REx-ID: 17442 | OA
Bravo JPK, Ramos DA, Fregoso Ocampo R, Ingram C, Taylor DW. 2024. Plasmid targeting and destruction by the DdmDE bacterial defence system. Nature. 630(8018), 961–967.
[Submitted Version] View | DOI | Download Submitted Version (ext.) | PubMed | Europe PMC
 
[20]
2024 | Published | Journal Article | IST-REx-ID: 17494 | OA
Bravo JPK. 2024. Anti-plasmid immunity: A key to pathogen success? Future Microbiology. 19(15), 1269–1272.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[19]
2023 | Published | Preprint | IST-REx-ID: 17112 | OA
Steens JA, Bravo JPK, Salazar CRP, Yildiz C, Amieiro AM, Köstlbacher S, Prinsen SHP, Patinios C, Bardis A, Barendregt A, Scheltema RA, Ettema TJG, van der Oost J, Taylor DW, Staals RHJ. 2023. Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages. bioRxiv, 10.1101/2023.06.23.546230.
[Preprint] View | DOI | Download Preprint (ext.)
 
[18]
2023 | Published | Journal Article | IST-REx-ID: 15129 | OA
O’Brien RE, Bravo JPK, Ramos D, Hibshman GN, Wright JT, Taylor DW. 2023. Structural snapshots of R-loop formation by a type I-C CRISPR Cascade. Molecular Cell. 83(5), 746–758.e5.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[17]
2023 | Published | Journal Article | IST-REx-ID: 15130 | OA
Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. 2023. RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature. 613(7944), 582–587.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[16]
2022 | Published | Preprint | IST-REx-ID: 17115 | OA
O’Brien RE, Bravo JPK, Ramos D, Hibshman GN, Wright JT, Taylor DW. 2022. Modes of inhibition used by phage anti-CRISPRs to evade type I-C Cascade. bioRxiv, 10.1101/2022.06.15.496202.
[Preprint] View | DOI | Download Preprint (ext.)
 
[15]
2022 | Submitted | Preprint | IST-REx-ID: 17116 | OA
Schwartz EA, Bravo JPK, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Fineran PC, Fagerlund RD, Taylor DW. Assembly of multi-subunit fusion proteins into the RNA-targeting type III-D CRISPR-Cas effector complex. bioRxiv, 10.1101/2022.06.13.496011.
[Preprint] View | DOI | Download Preprint (ext.)
 
[14]
2022 | Published | Preprint | IST-REx-ID: 17117 | OA
Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. 2022. Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2. bioRxiv, 10.1101/2022.06.13.495754.
[Preprint] View | DOI | Download Preprint (ext.)
 
[13]
2022 | Published | Journal Article | IST-REx-ID: 15131 | OA
Yelland JN, Bravo JPK, Black JJ, Taylor DW, Johnson AW. 2022. A single 2′-O-methylation of ribosomal RNA gates assembly of a functional ribosome. Nature Structural & Molecular Biology. 30, 91–98.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[12]
2022 | Published | Journal Article | IST-REx-ID: 15132
Bravo JPK, Hibshman GN, Taylor DW. 2022. Constructing next-generation CRISPR–Cas tools from structural blueprints. Current Opinion in Biotechnology. 78, 102839.
View | DOI | PubMed | Europe PMC
 
[11]
2022 | Published | Journal Article | IST-REx-ID: 15133 | OA
Bravo JPK, Aparicio-Maldonado C, Nobrega FL, Brouns SJJ, Taylor DW. 2022. Structural basis for broad anti-phage immunity by DISARM. Nature Communications. 13, 2987.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[10]
2022 | Published | Journal Article | IST-REx-ID: 15134 | OA
Schwartz EA, McBride TM, Bravo JPK, Wrapp D, Fineran PC, Fagerlund RD, Taylor DW. 2022. Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nature Communications. 13, 2829.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[9]
2022 | Published | Journal Article | IST-REx-ID: 15136 | OA
Bravo JPK, Liu M-S, Hibshman GN, Dangerfield TL, Jung K, McCool RS, Johnson KA, Taylor DW. 2022. Structural basis for mismatch surveillance by CRISPR–Cas9. Nature. 603(7900), 343–347.
[Published Version] View | Files available | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[8]
2022 | Published | Journal Article | IST-REx-ID: 15144
Bravo JPK. 2022. SuperFi-Cas9 exceeds fidelity, matches speed of original Cas9. Genetic Engineering & Biotechnology News. 42(4), 12.
View | DOI
 
[7]
2021 | Published | Journal Article | IST-REx-ID: 15137 | OA
Steens JA, Zhu Y, Taylor DW, Bravo JPK, Prinsen SHP, Schoen CD, Keijser BJF, Ossendrijver M, Hofstra LM, Brouns SJJ, Shinkai A, van der Oost J, Staals RHJ. 2021. SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation. Nature Communications. 12, 5033.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[6]
2021 | Published | Journal Article | IST-REx-ID: 15138 | OA
Geiger F, Acker J, Papa G, Wang X, Arter WE, Saar KL, Erkamp NA, Qi R, Bravo JPK, Strauss S, Krainer G, Burrone OR, Jungmann R, Knowles TP, Engelke H, Borodavka A. 2021. Liquid–liquid phase separation underpins the formation of replication factories in rotaviruses. The EMBO Journal. 40(21), e107711.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[5]
2021 | Published | Journal Article | IST-REx-ID: 15139 | OA
Bravo JPK, Bartnik K, Venditti L, Acker J, Gail EH, Colyer A, Davidovich C, Lamb DC, Tuma R, Calabrese AN, Borodavka A. 2021. Structural basis of rotavirus RNA chaperone displacement and RNA annealing. Proceedings of the National Academy of Sciences. 118(41), e2100198118.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[4]
2021 | Published | Journal Article | IST-REx-ID: 15140 | OA
Bravo JPK, Dangerfield TL, Taylor DW, Johnson KA. 2021. Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication. Molecular Cell. 81(7), 1548–1552.e4.
[Preprint] View | DOI | Download Preprint (ext.) | PubMed | Europe PMC
 
[3]
2021 | Published | Journal Article | IST-REx-ID: 15141 | OA
Zhou Y, Bravo JPK, Taylor HN, Steens JA, Jackson RN, Staals RHJ, Taylor DW. 2021. Structure of a type IV CRISPR-Cas ribonucleoprotein complex. iScience. 24(3), 102201.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[2]
2020 | Published | Journal Article | IST-REx-ID: 15142 | OA
O’Brien RE, Santos IC, Wrapp D, Bravo JPK, Schwartz EA, Brodbelt JS, Taylor DW. 2020. Structural basis for assembly of non-canonical small subunits into type I-C Cascade. Nature Communications. 11, 5931.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[1]
2018 | Published | Journal Article | IST-REx-ID: 15143 | OA
Bravo JPK, Borodavka A, Barth A, Calabrese AN, Mojzes P, Cockburn JJB, Lamb DC, Tuma R. 2018. Stability of local secondary structure determines selectivity of viral RNA chaperones. Nucleic Acids Research. 46(15), 7924–7937.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
Marked Publication(s)

Search

Filter Publications

Display / Sort

Citation Style: ISTA Annual Report

Export / Embed

Grants


28 Publications

Mark all

[28]
2025 | Published | Journal Article | IST-REx-ID: 18848 | OA
Ocampo RF, Bravo JPK, Dangerfield TL, Nocedal I, Jirde SA, Alexander LM, Thomas NC, Das A, Nielson S, Johnson KA, Brown CT, Butterfield CN, Goltsman DSA, Taylor DW. 2025. DNA targeting by compact Cas9d and its resurrected ancestor. Nature Communications. 16, 457.
[Published Version] View | Files available | DOI | PubMed | Europe PMC
 
[27]
2025 | In Press | Journal Article | IST-REx-ID: 20143 | OA | PlanS
Zhang Z, Todeschini TC, Wu Y, Kogay R, Naji A, Cardenas Rodriguez J, Mondi R, Kaganovich D, Taylor DW, Bravo JPK, Teplova M, Amen T, Koonin E, Patel DJ, Nobrega FL. Kiwa is a membrane-embedded defense supercomplex activated at phage attachment sites. Cell.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[26]
2024 | Published | Journal Article | IST-REx-ID: 17113 | OA
Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. 2024. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nature Communications. 15, 3663.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[25]
2024 | Published | Journal Article | IST-REx-ID: 17114 | OA
Schwartz EA, Bravo JPK, Ahsan M, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Palermo G, Fineran PC, Fagerlund RD, Taylor DW. 2024. RNA targeting and cleavage by the type III-Dv CRISPR effector complex. Nature Communications. 15, 3324.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[24]
2024 | Published | Journal Article | IST-REx-ID: 18545 | OA
Degtev D, Bravo JPK, Emmanouilidi A, Zdravković A, Choong OK, Liz Touza J, Selfjord N, Weisheit I, Francescatto M, Akcakaya P, Porritt M, Maresca M, Taylor D, Sienski G. 2024. Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles. Nature Communications. 15, 9173.
[Published Version] View | Files available | DOI
 
[23]
2024 | Published | Journal Article | IST-REx-ID: 17111
Kamatar A, Bravo JPK, Yuan F, Wang L, Lafer EM, Taylor DW, Stachowiak JC, Parekh SH. 2024. Lipid droplets as substrates for protein phase separation. Biophysical Journal. 123(11), 1494–1507.
View | DOI | PubMed | Europe PMC
 
[22]
2024 | Published | Journal Article | IST-REx-ID: 15372 | OA
Hibshman GN, Bravo JPK, Hooper MM, Dangerfield TL, Zhang H, Finkelstein IJ, Johnson KA, Taylor DW. 2024. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9. Nature Communications. 15, 3663.
[Published Version] View | Files available | DOI | PubMed | Europe PMC
 
[21]
2024 | Published | Journal Article | IST-REx-ID: 17442 | OA
Bravo JPK, Ramos DA, Fregoso Ocampo R, Ingram C, Taylor DW. 2024. Plasmid targeting and destruction by the DdmDE bacterial defence system. Nature. 630(8018), 961–967.
[Submitted Version] View | DOI | Download Submitted Version (ext.) | PubMed | Europe PMC
 
[20]
2024 | Published | Journal Article | IST-REx-ID: 17494 | OA
Bravo JPK. 2024. Anti-plasmid immunity: A key to pathogen success? Future Microbiology. 19(15), 1269–1272.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[19]
2023 | Published | Preprint | IST-REx-ID: 17112 | OA
Steens JA, Bravo JPK, Salazar CRP, Yildiz C, Amieiro AM, Köstlbacher S, Prinsen SHP, Patinios C, Bardis A, Barendregt A, Scheltema RA, Ettema TJG, van der Oost J, Taylor DW, Staals RHJ. 2023. Type III-B CRISPR-Cas signaling-based cascade of proteolytic cleavages. bioRxiv, 10.1101/2023.06.23.546230.
[Preprint] View | DOI | Download Preprint (ext.)
 
[18]
2023 | Published | Journal Article | IST-REx-ID: 15129 | OA
O’Brien RE, Bravo JPK, Ramos D, Hibshman GN, Wright JT, Taylor DW. 2023. Structural snapshots of R-loop formation by a type I-C CRISPR Cascade. Molecular Cell. 83(5), 746–758.e5.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[17]
2023 | Published | Journal Article | IST-REx-ID: 15130 | OA
Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. 2023. RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2. Nature. 613(7944), 582–587.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[16]
2022 | Published | Preprint | IST-REx-ID: 17115 | OA
O’Brien RE, Bravo JPK, Ramos D, Hibshman GN, Wright JT, Taylor DW. 2022. Modes of inhibition used by phage anti-CRISPRs to evade type I-C Cascade. bioRxiv, 10.1101/2022.06.15.496202.
[Preprint] View | DOI | Download Preprint (ext.)
 
[15]
2022 | Submitted | Preprint | IST-REx-ID: 17116 | OA
Schwartz EA, Bravo JPK, Macias LA, McCafferty CL, Dangerfield TL, Walker JN, Brodbelt JS, Fineran PC, Fagerlund RD, Taylor DW. Assembly of multi-subunit fusion proteins into the RNA-targeting type III-D CRISPR-Cas effector complex. bioRxiv, 10.1101/2022.06.13.496011.
[Preprint] View | DOI | Download Preprint (ext.)
 
[14]
2022 | Published | Preprint | IST-REx-ID: 17117 | OA
Bravo JPK, Hallmark T, Naegle B, Beisel CL, Jackson RN, Taylor DW. 2022. Large-scale structural rearrangements unleash indiscriminate nuclease activity of CRISPR-Cas12a2. bioRxiv, 10.1101/2022.06.13.495754.
[Preprint] View | DOI | Download Preprint (ext.)
 
[13]
2022 | Published | Journal Article | IST-REx-ID: 15131 | OA
Yelland JN, Bravo JPK, Black JJ, Taylor DW, Johnson AW. 2022. A single 2′-O-methylation of ribosomal RNA gates assembly of a functional ribosome. Nature Structural & Molecular Biology. 30, 91–98.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[12]
2022 | Published | Journal Article | IST-REx-ID: 15132
Bravo JPK, Hibshman GN, Taylor DW. 2022. Constructing next-generation CRISPR–Cas tools from structural blueprints. Current Opinion in Biotechnology. 78, 102839.
View | DOI | PubMed | Europe PMC
 
[11]
2022 | Published | Journal Article | IST-REx-ID: 15133 | OA
Bravo JPK, Aparicio-Maldonado C, Nobrega FL, Brouns SJJ, Taylor DW. 2022. Structural basis for broad anti-phage immunity by DISARM. Nature Communications. 13, 2987.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[10]
2022 | Published | Journal Article | IST-REx-ID: 15134 | OA
Schwartz EA, McBride TM, Bravo JPK, Wrapp D, Fineran PC, Fagerlund RD, Taylor DW. 2022. Structural rearrangements allow nucleic acid discrimination by type I-D Cascade. Nature Communications. 13, 2829.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[9]
2022 | Published | Journal Article | IST-REx-ID: 15136 | OA
Bravo JPK, Liu M-S, Hibshman GN, Dangerfield TL, Jung K, McCool RS, Johnson KA, Taylor DW. 2022. Structural basis for mismatch surveillance by CRISPR–Cas9. Nature. 603(7900), 343–347.
[Published Version] View | Files available | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[8]
2022 | Published | Journal Article | IST-REx-ID: 15144
Bravo JPK. 2022. SuperFi-Cas9 exceeds fidelity, matches speed of original Cas9. Genetic Engineering & Biotechnology News. 42(4), 12.
View | DOI
 
[7]
2021 | Published | Journal Article | IST-REx-ID: 15137 | OA
Steens JA, Zhu Y, Taylor DW, Bravo JPK, Prinsen SHP, Schoen CD, Keijser BJF, Ossendrijver M, Hofstra LM, Brouns SJJ, Shinkai A, van der Oost J, Staals RHJ. 2021. SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation. Nature Communications. 12, 5033.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[6]
2021 | Published | Journal Article | IST-REx-ID: 15138 | OA
Geiger F, Acker J, Papa G, Wang X, Arter WE, Saar KL, Erkamp NA, Qi R, Bravo JPK, Strauss S, Krainer G, Burrone OR, Jungmann R, Knowles TP, Engelke H, Borodavka A. 2021. Liquid–liquid phase separation underpins the formation of replication factories in rotaviruses. The EMBO Journal. 40(21), e107711.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[5]
2021 | Published | Journal Article | IST-REx-ID: 15139 | OA
Bravo JPK, Bartnik K, Venditti L, Acker J, Gail EH, Colyer A, Davidovich C, Lamb DC, Tuma R, Calabrese AN, Borodavka A. 2021. Structural basis of rotavirus RNA chaperone displacement and RNA annealing. Proceedings of the National Academy of Sciences. 118(41), e2100198118.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[4]
2021 | Published | Journal Article | IST-REx-ID: 15140 | OA
Bravo JPK, Dangerfield TL, Taylor DW, Johnson KA. 2021. Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication. Molecular Cell. 81(7), 1548–1552.e4.
[Preprint] View | DOI | Download Preprint (ext.) | PubMed | Europe PMC
 
[3]
2021 | Published | Journal Article | IST-REx-ID: 15141 | OA
Zhou Y, Bravo JPK, Taylor HN, Steens JA, Jackson RN, Staals RHJ, Taylor DW. 2021. Structure of a type IV CRISPR-Cas ribonucleoprotein complex. iScience. 24(3), 102201.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[2]
2020 | Published | Journal Article | IST-REx-ID: 15142 | OA
O’Brien RE, Santos IC, Wrapp D, Bravo JPK, Schwartz EA, Brodbelt JS, Taylor DW. 2020. Structural basis for assembly of non-canonical small subunits into type I-C Cascade. Nature Communications. 11, 5931.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
[1]
2018 | Published | Journal Article | IST-REx-ID: 15143 | OA
Bravo JPK, Borodavka A, Barth A, Calabrese AN, Mojzes P, Cockburn JJB, Lamb DC, Tuma R. 2018. Stability of local secondary structure determines selectivity of viral RNA chaperones. Nucleic Acids Research. 46(15), 7924–7937.
[Published Version] View | DOI | Download Published Version (ext.) | PubMed | Europe PMC
 
Marked Publication(s)

Search

Filter Publications

Display / Sort

Citation Style: ISTA Annual Report

Export / Embed